Fingerprint
Dive into the research topics of 'Phase 2 study of gandotinib (LY2784544) in patients with myeloproliferative neoplasms'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase 2 study of gandotinib (LY2784544) in patients with myeloproliferative neoplasms
J. Berdeja, F. Palandri, M. R. Baer, D. Quick, J. J. Kiladjian, G. Martinelli, A. Verma, O. Hamid, R. Walgren, C. Pitou, P. L. Li, A. T. Gerds
Research output: Contribution to journal › Article › peer-review
41
Scopus
citations